Skip to main content

Arcutis Biotherapeutics, Inc.

ARQTNASDAQ
$25.15-0.01 (-0.04%)as of Oct 5, 2026
Legend
Insider buy
Insider sell
Congress buy
Congress sell
Hedge Funds
bought vs sold
Greener markers show more buyers; redder markers show more sellers.
Company share activityNet buybacksNo changeNet dilution
Marker size reflects transaction size.
  • Insider buy
  • Insider sell
  • Congress buy
  • Congress sell
  • Hedge Funds bought vs sold
Share activityNet buybacksNo changeNet dilution

Marker size reflects transaction size. Greener fund markers mean more buyers.

  • Insider Buy
  • Insider Sell
  • Congress Buy
  • Congress Sell
  • Hedge funds bought vs sold
  • BuybackNo changeNet dilution

Arcutis Biotherapeutics, Inc. price and activity chart data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (+27.3%). 0 insider or congressional trades plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding

Largest institutional holders

13F · Q2 2026
Fund% of company heldValue% of portfolioQuarterly activity
Montanova Capital, LLC9.90%$326M5.96%Add 0.89%
BlackRock, Inc.8.40%$277M0.00%Not reported
Frazier Life Sciences Management, L.P.7.86%$259M5.64%Not reported
Rubric Capital Management LP6.59%$217M1.99%Not reported
Polar Capital Holdings Plc5.26%$173M0.41%Add 16.59%
State Street Corp4.64%$153M0.00%Not reported
Vanguard Capital Management LLC3.97%$131M0.00%Not reported
Morgan Stanley3.54%$117M0.01%Not reported
Jennison Associates LLC3.36%$111M0.07%Reduce 15.29%
D. E. Shaw & Co., Inc.3.14%$104M0.05%Not reported
UBS Group AG2.65%$87.4M0.01%Not reported
Bank of America Corp2.38%$78.3M0.01%Not reported
Geode Capital Management, LLC2.37%$78.2M0.00%Not reported
Vanguard Portfolio Management LLC1.93%$63.7M0.00%Not reported
Orbimed Advisors LLC1.63%$53.5M0.99%Not reported
American Century Companies Inc1.53%$50.5M0.02%Not reported
Goldman Sachs Group Inc1.33%$43.7M0.00%Not reported
Jupiter Topco LLC1.12%$37M0.02%Not reported
Oberweis Asset Management Inc/1.09%$36M0.74%Add 0.51%
Gilder Gagnon Howe & Co LLC1.05%$34.4M0.36%Reduce 69.49%
GW&K Investment Management, LLC1.03%$33.8M0.26%Not reported
Pivotal bioVenture Partners Investment Advisor LLC1.01%$33.2M10.78%Reduce 6.68%
Bamco Inc1.00%$32.9M0.05%Add 16.87%
Citadel Advisors LLC0.92%$30.4M0.00%Not reported
Federated Hermes, Inc.0.90%$29.5M0.04%Not reported
Perpetual Ltd0.88%$29.1M0.42%Add 22.00%
Aberdeen Group plc0.87%$28.8M0.04%Add 70.28%
Jones Hill Capital LP0.87%$28.6M6.07%New Not reported
Northern Trust Corp0.84%$27.8M0.00%Not reported
Charles Schwab Investment Management Inc0.84%$27.6M0.00%Not reported
Ensign Peak Advisors, Inc0.78%$25.6M0.04%Reduce 21.69%
Driehaus Capital Management LLC0.70%$23M0.13%Reduce 60.54%
Nuveen, LLC0.66%$21.9M0.01%Not reported
Vanguard Fiduciary Trust Co0.65%$21.4M0.00%Not reported
Manufacturers Life Insurance Company, the0.65%$21.3M0.02%Not reported
Two Sigma Investments, LP0.53%$17.4M0.01%Not reported
Fishman Jay A Ltd0.47%$15.6M1.24%Add 4.99%
Millennium Management LLC0.45%$14.8M0.01%Not reported
BNP Paribas Financial Markets0.44%$14.3M0.01%Not reported
Squarepoint Ops LLC0.43%$14.1M0.02%Not reported
Capitolis Liquid Global Markets LLC0.40%$13.1M0.06%Not reported
Nearwater Capital Markets, Ltd0.39%$12.8M0.22%Reduce 19.86%
Adage Capital Partners GP, L.L.C.0.37%$12.2M0.02%Add 27.32%
Marshall Wace, LLP0.36%$11.7M0.01%Not reported
Privium Fund Management B.V.0.32%$10.5M1.92%Add 24.42%
Norges Bank0.31%$10.3M0.00%Not reported
Deutsche Bank Ag\0.30%$10M0.00%Not reported
Patient Square Capital LP0.29%$9.7M1.50%Reduce 7.65%
Point72 Asset Management, L.P.0.29%$9.5M0.01%Not reported
Qube Research & Technologies Ltd0.29%$9.48M0.01%Not reported
50 of 258 holders

Activity score

Premium
0
25
50
75
100
WEAK
STRONG
Unlock

AI Activity Analysis

Premium
Coming soonAI reads of insider, institutional and company activity will appear here for Premium accounts.

Historical Activity Patterns

Premium
Historical Activity PatternsHistorical periods where multiple activity categories converged, with subsequent market performance shown for context.Unlock

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.